Author

L. J. Brandes

Observed names: L BRANDES, L Brandes, L J Brandes, L. Brandes, L.J. BRANDES, L.J. Brandes

Institution: University Hospital Regensburg

Observed institutions: University of Southern California, Cleveland Clinic, University of Toronto, Queen's University, Toronto Western Hospital, Princess Margaret Cancer Centre, University Hospital Regensburg, CancerCare Manitoba, Bristol-Myers Squibb (Canada), Canadian Cancer Trials Group, University of Manitoba

OpenAlex ID: A5111602453

Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.

1992 · L J Brandes, R J Arron, et al. · PubMed · 211

Increased Therapeutic Index of Antineoplastic Drugs in Combination With Intracellular Histamine Antagonists

1991 · L. J. Brandes, F. S. LaBella, et al. · JNCI Journal of the National Cancer Institute · 58

H3 receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450

1992 · F.S. LaBella, G. Queen, et al. · British Journal of Pharmacology · 56

Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.

1987 · L J Brandes, R P Bogdanovic, et al. · PubMed · 55

Enhanced Cancer Growth in Mice Administered Daily Human-Equivalent Doses of Some H1-Antihistamines: Predictive In Vitro Correlates

1994 · L. J. Brandes, R. C. Warrington, et al. · JNCI Journal of the National Cancer Institute · 49

Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents.

1994 · L J Brandes, K J Simons, et al. · Journal of Clinical Oncology · 39

Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation.

1988 · L J Brandes, J M Gerrard, et al. · PubMed · 36

N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer.

1995 · L J Brandes, S P Bracken, et al. · Journal of Clinical Oncology · 35

Phase Ii Trial of Tesmilifene Plus Mitoxantrone and Prednisone for Hormone Refractory Prostate Cancer: High Subjective and Objective Response in Patients With Symptomatic Metastases

2005 · D. RAGHAVAN, L.J. BRANDES, et al. · The Journal of Urology · 27

Histamine in Normal and Cancer Cell Proliferation

1993 · M. García-Caballero, L. J. Brandes, et al. · 26

The Antiproliferative Potency of Histamine Antagonists Correlates with Inhibition of Binding of [3H]-Histamine to Novel Intracellular Receptors (HIC) in Microsomal and Nuclear Fractions of Rat Liver

1991 · L. J. Brandes, J. R. Davie, et al. · Birkhäuser Basel eBooks · 23

Phase II Trial of N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl and Doxorubicin Chemotherapy in Metastatic Breast Cancer: A National Cancer Institute of Canada Clinical Trials Group Study

1999 · K. Khoo, L. Brandes, et al. · Journal of Clinical Oncology · 17

Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand

1990 · L. J. Brandes, G. R. Hogg · Reproduction · 16

PDF

A role for intracellular histamine in ultrastructural changes induced in platelets by phorbol esters.

1989 · A McNicol, S P Saxena, et al. · Arteriosclerosis An Official Journal of the American Heart Association Inc · 12

An evaluation of the peripheral leukocyte migration inhibition test as a correlate of delayed cutaneous hypersensitivity

1976 · E.W. Ramsey, L.J. Brandes, et al. · Cellular Immunology · 12

Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.

1987 · K Wilson, W Shelley, et al. · PubMed · 10

Murine and human hematopoietic colony formation: a possible regulatory role for intracellular histamine

2002 · M. Bencsáth, J. Gidáli, et al. · Acta Biologica Hungarica · 9

Can the clinical course of cancer be influenced by non-antineoplastic drugs?

1995 · L J Brandes, L A Friesen · Europe PMC (PubMed Central) · 9

Further Studies on the Effects of the Intracellular Histamine Antagonist DPPE on Platelet Function

1991 · A. McNicol, S. P. Saxena, et al. · Platelets · 9

The effect of skin testing on cellular immunity as measured in vitro by leukocyte migration inhibition

1977 · E.W. Ramsey, L.J. Brandes, et al. · Cellular Immunology · 9

Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activity.

1985 · G J Goldenberg, L J Brandes, et al. · PubMed · 7

PI-12Amantadine acetylation as a biomarker for malignancy

2006 · D SITAR, A BRAS, et al. · Clinical Pharmacology & Therapeutics · 4

Mammalian neurons in dissociated cultures form clusters in the presence of retinal pigment epithelium

1991 · J.F. MacDonald, L. Brandes, et al. · Experimental Brain Research · 4

Immunotherapy for Ovarian Cancer

1976 · L BRANDES · The Lancet · 3

Abstract P5-14-02: Clinical predictors of benefit from fulvestrant in advanced breast cancer: A meta-analysis of randomized controlled trials

2016 · S Niraula, M Pitz, et al. · Cancer Research · 1

Works count: 29

Citation count: 737

H-index: 13

I10-index: 16